Inhibrx Biosciences, Inc.INBXNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
|
|
|
|

Free cash flow yield

Latest
-88.37%
↓ 482% below average
Average (8y)
-15.19%
Historical baseline
Range
High:-2.43%
Low:-88.37%
CAGR
+56.7%
Consistent expansion
PeriodValueChange
2024-88.37%-699.7%
2023-11.05%+5.8%
2022-11.74%-140.0%
2021-4.89%+17.4%
2020-5.92%-31.8%
2019-4.49%-2.4%
2018-4.39%-29.8%
2017-3.38%-39.2%
2016-2.43%-